Zalutumumab in Non-curable Patients With SCCHN (Q65380032)
Jump to navigation
Jump to search
clinical trial
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Zalutumumab in Non-curable Patients With SCCHN |
clinical trial |
Statements
An Open Label Single Arm Trial Investigating Zalutumumab, a Human Monoclonal Anti-EGF Receptor Antibody, in Combination With Best Supportive Care, in Patients With Non-Curable Squamous Cell Carcinoma of the Head and Neck Who Have Failed Standard Platinum-based Chemotherapy. (English)
0 references
January 2008
0 references
August 2011
0 references
90
0 references
18 year
0 references